Nephrogenic Systemic Fibrosis

Jeffrey C. Weinreb, Phillip H Kuo

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

There seems to be an association between exposure to intravenous gadolinium-based contrast agents (GBCAs) and nephrogenic systemic fibrosis (NSF), a debilitating and sometimes fatal disease. This article addresses the relationship between GBCAs and NSF and answers some common questions. The policy deployed at Yale-New Haven Hospital for prevention of NSF and screening for patients at risk is delineated and discussed along with recommendations by the Food and Drug Administration.

Original languageEnglish (US)
Pages (from-to)159-167
Number of pages9
JournalMagnetic Resonance Imaging Clinics of North America
Volume17
Issue number1
DOIs
StatePublished - Feb 2009

Fingerprint

Nephrogenic Fibrosing Dermopathy
Gadolinium
Contrast Media
United States Food and Drug Administration

Keywords

  • Gadolinium
  • Gadolinium chelates
  • Gadolinium-based contrast agent
  • MR contrast agents
  • MR imaging
  • Nephrogenic systemic fibrosis

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Nephrogenic Systemic Fibrosis. / Weinreb, Jeffrey C.; Kuo, Phillip H.

In: Magnetic Resonance Imaging Clinics of North America, Vol. 17, No. 1, 02.2009, p. 159-167.

Research output: Contribution to journalArticle

Weinreb, Jeffrey C. ; Kuo, Phillip H. / Nephrogenic Systemic Fibrosis. In: Magnetic Resonance Imaging Clinics of North America. 2009 ; Vol. 17, No. 1. pp. 159-167.
@article{668d84094e9e4301aa06b42e04c8778a,
title = "Nephrogenic Systemic Fibrosis",
abstract = "There seems to be an association between exposure to intravenous gadolinium-based contrast agents (GBCAs) and nephrogenic systemic fibrosis (NSF), a debilitating and sometimes fatal disease. This article addresses the relationship between GBCAs and NSF and answers some common questions. The policy deployed at Yale-New Haven Hospital for prevention of NSF and screening for patients at risk is delineated and discussed along with recommendations by the Food and Drug Administration.",
keywords = "Gadolinium, Gadolinium chelates, Gadolinium-based contrast agent, MR contrast agents, MR imaging, Nephrogenic systemic fibrosis",
author = "Weinreb, {Jeffrey C.} and Kuo, {Phillip H}",
year = "2009",
month = "2",
doi = "10.1016/j.mric.2009.01.003",
language = "English (US)",
volume = "17",
pages = "159--167",
journal = "Magnetic Resonance Imaging Clinics of North America",
issn = "1064-9689",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Nephrogenic Systemic Fibrosis

AU - Weinreb, Jeffrey C.

AU - Kuo, Phillip H

PY - 2009/2

Y1 - 2009/2

N2 - There seems to be an association between exposure to intravenous gadolinium-based contrast agents (GBCAs) and nephrogenic systemic fibrosis (NSF), a debilitating and sometimes fatal disease. This article addresses the relationship between GBCAs and NSF and answers some common questions. The policy deployed at Yale-New Haven Hospital for prevention of NSF and screening for patients at risk is delineated and discussed along with recommendations by the Food and Drug Administration.

AB - There seems to be an association between exposure to intravenous gadolinium-based contrast agents (GBCAs) and nephrogenic systemic fibrosis (NSF), a debilitating and sometimes fatal disease. This article addresses the relationship between GBCAs and NSF and answers some common questions. The policy deployed at Yale-New Haven Hospital for prevention of NSF and screening for patients at risk is delineated and discussed along with recommendations by the Food and Drug Administration.

KW - Gadolinium

KW - Gadolinium chelates

KW - Gadolinium-based contrast agent

KW - MR contrast agents

KW - MR imaging

KW - Nephrogenic systemic fibrosis

UR - http://www.scopus.com/inward/record.url?scp=64049111785&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64049111785&partnerID=8YFLogxK

U2 - 10.1016/j.mric.2009.01.003

DO - 10.1016/j.mric.2009.01.003

M3 - Article

VL - 17

SP - 159

EP - 167

JO - Magnetic Resonance Imaging Clinics of North America

JF - Magnetic Resonance Imaging Clinics of North America

SN - 1064-9689

IS - 1

ER -